¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Resin, bile acid"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • saccharic acid
    »çÄ«¸°»ê
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • sorbic acid
    ¼Ò¸£ºê»ê
  • spermanucleic acid
    Á¤ÀÚÇÙ»ê
  • stearic acid
    ½ºÅ׾Ƹ£»ê
  • succinic acid
    ¼÷½Å»ê
  • sugar acid
    ´ç»ê
  • sulfuric acid
    Ȳ»ê
  • sulfurous acid
    ¾ÆÈ²»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • sialic acid
    ½Ã¾Ë»ê
  • taurocholic acid
    Ÿ¿ì·ÎÄÝ»ê
  • teichoic acid
    Å×ÀÌÄÚ»ê
  • teichuronic acid
    Å×ÀÌÅ¥·Ð»ê
  • tannic acid
    ź´Ñ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • nucleic acid probe
    ÇÙ»ê´õµëÀÚ
  • uric acid nephropathy
    (¢¡urate nephropathy) ¿ä»ê¿°ÄáÆÏº´Áõ
  • periodic acid-Schiff stain
    ÇÇ¿¡ÀÌ¿¡½º¿°»ö
  • uric acid stone
    ¿ä»êµ¹
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • pyrophosphoric acid
    ÇÇ·ÎÀλê(¡­ìÝß«).
  • pyrosulfuric acid
    ÇÇ·ÎȲ»ê(¡­üÜß«).
  • pyrotartarid acid
    ÇǷΟ¸£Å¸¸£»ê(¡­ß«).
  • pyruvic acid
    ÇÇ·çºó»ê(¡­ß«).
  • pyuria, acid
    »ê¼º³ó´¢
  • regulation of acid base equilibrium
    »ê-¿°±âÆòÇüÁ¶Àý(ß«ç¤ÐñøÁû¬ðàï½).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • anthranilic acid
    ¾ÈÆ®¶ó´Ò»ê.
  • apoascorbic acid
    ¾ÆÆ÷¾Æ½ºÄÚ¸£ºó»ê.
  • arachidonic acid
    ¾Æ¶ó۵·»ê
  • arachidonic acid
    ¾Æ¶ó۵·»ê(¡­ß«)
  • arachidonic acid metabolism
    ¾Æ¶ó۵·»ê´ë»ç
  • arachidonic acid metabolites
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú(¡­ÓÛÞóÚªòõ)
  • arginine-glycine-aspartic acid
    Arginine-glycine-aspartic acid
  • aromatic amino acid
    ¹æÇâÁ·¾Æ¹Ì³ë»ê.
  • arormatic amino acid
    ¹æÇâÁ·¾Æ¹Ì³ë»ê
  • arsenic acid
    ºñ»ê(Ý÷ß«).
  • arsenoacetic acid
    ¾Æ¸£¼¼³ë¾Æ¼¼Æ®»ê.
  • arsenous acid
    ¾Æºñ»ê(ä¬Ý÷ß«).
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê.
  • ascorbic acid
    ¾Æ½ºÄÚ¸£ºó»ê(¡­ß«)
  • ascorbic acid = vitamin C
    ¾Æ½ºÄÚ¸£ºó»ê = ºñŸ¹Î C
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
  • Lewis acid
    ·çÀ̽º»ê(ß«)
  • Lewis acid-base catalysis
    ·çÀ̽º »ê-¿°±â(ß«.ç¤Ðñ) Ã˸ÅÀÛ¿ë(ç¤Ðñ õºØÚÚãëë)
  • lignoceric acid
    ¸®±×³ë¼¼¸£»ê(ß«)
  • limiting amino acid
    Á¦ÇÑ(ð¤ùÚ)¾Æ¹Ì³ë»ê(ß«)
  • linoleic acid
    ¸®³î·¹»ê(ß«)
  • linolenic acid
    ·¹³î·»»ê(ß«)
  • lipamino acid
    ¸®ÆÄ¹Ì³ë»ê(ß«)
  • lipoamino acid
    ÁöÁú(ò·òõ)¾Æ¹Ì³ë»ê(ß«)
  • lipoic acid
    ¸®Æ÷»ê(ß«)
  • lithocholic acid
    ¸®ÅäÄÝ»ê(ß«)
  • long-chain fatty acid thiokinase
    ±ä»ç½½Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • lysergic acid diethylamide
    ¸®¼­¸£±×»ê(ß«) ÀÌ(ì£)¿¡Ä¥¾Æ¸¶À̵å
  • maleic acid
    ¸»·¹»ê(ß«)
  • malic acid
    ¸»»ê(ß«)
  • malonic acid
    ¸»·Ð»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
DPA D-penicillamine; Department of Public Assistance; diphenylalanine; dipicolinic acid; dipropylacetic ...
EAA electroacupuncture analgesia; Epilepsy Association of America; essential amino acid; excitatory amin...
FAA folic acid antagonist; formaldehyde, acetic acid, alcohol
FAP familial adenomatous polyposis; familial amyloid polyneuropathy; fatty acid polyunsaturated; fatty a...
FPN ferric chloride, perchloric acid, and nitric acid [solution]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 14
15-HPETE 15(S)-hydroperoxyeicosatetraenoic acid
IPPA 15-(4'-iodophenyl)pentadecanoic acid
17-ODYA 17-octadecenoic acid
MES 2(N-Morpholino)ethanesulfonic acid
2, 3-DHBA 2, 3-dihydroxybenzoic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pantotheic acid
    ÆÇÅäÅÙ»ê
  • pantothenic acid
    ÆÇÅäÅÙ»ê
  • para- : ºÎ, ÁÖÀ§, ¹æ, ±Ù, ±Ù»ç, ¿ø ¹× ÀÌ µîÀÇ ¶æÀ» ³ªÅ¸³»´Â Á¢µÎ¾î.

    para-amino salicylic acid

    ÆÄ¶ó-¾Æ¹Ì³ë »ì¸®½Ç »ê
    ÇÕ¼ºµÈ Ç×°áÇÙ ¾àÀ¸·Î Ç×±Õ ÀÛ¿ëÀº °áÇÙ ±Õ¿¡ ƯÀÌÀûÀÌ¸ç ´Ù¸¥ º´¿ø ±Õ¿¡ ÀÛ¿ëÇÏÁö ¾Ê´Â´Ù. È­ÇÐ ±¸Á¶´Â »ì¸®½Ç »ê°ú À¯»çÇϳª ÁßÃß ½Å°æ°è¿¡ ´ëÇÑ ÀÛ¿ëÀº °ÅÀÇ ¾ø´Ù. ÀÛ¿ë ±âÀüÀº ¸íÈ®ÇÏÁö ¾ÊÀ¸¸ç ´ë»ç ±æÇ×Á¦, È£Èí »ê¼Ò ÀúÇØ¼³ÀÌ ÀÖ´Ù. ½ÃÇè°ü ³»ÀÇ Ç×±Õ ÀÛ¿ëÀº °­ÇÏÁö¸¸ Ç׿°Àº ¾ÆÀ̼ҳªÀ̾ÆÁö, ½ºÆ®·¾Å丶À̽ź¸´Ù ¾à°£ ¾àÇÏ¸ç ´ë·®ÀÇ º¹¿ëÀ» ¿äÇÑ´Ù. ½ºÆ®·¾Å丶À̽ź¸´Ù ³»¼º ÃâÇöÀÌ ´Ê´Ù. ´Üµ¶º¸´Ù ½ºÆ®·¾Å丶À̽Å, ¾ÆÀ̼ҳªÀ̾ÆÁöµå¿ÍÀÇ º´¿ëÀº È¿°ú Áõ°­°ú ³»¼º ¹ßÇöÀÇ Áö¿¬È­¸¦ ³ë¸°´Ù. µ¶¼ºÀº ÀÛÀ¸¸ç ºÎÀÛ¿ëÀÇ ÁÖµÈ °ÍÀº ¼ÒÈ­°ü¿¡ ´ëÇÑ ±¹¼Ò Àڱؿ¡ ÀÇÇÑ °Í
  • paraaminohippuric acid
    ÆÄ¶ó ¾Æ¹Ì³ë¸¶´¢»ê, ÆÄ¶ó ¾Æ¹Ì³ëÈ÷Ǫ¸£»ê
    ¾Æ¹Ì³ë ¾È½ÄÇâ»êÀÇ N-ÃÊ»ê. C
  • pentonic acid
    ÆæÅæ»ê
  • performic acid
    °úÀÇ»ê
    cysteinÀ» »êÈ­ÇÏ¿© cysteic acid·Î ÇÏ¿© ÆéŸÀ̵åÀÇ disulfide °áÇÕÀ» Âɰ³±â À§ÇÏ¿© »ç¿ëµÇ´Â À¯±â°ú»ê¼Ò»ê.
  • permanganic acid
    °ú¸Á°£»ê
    ÀÏ ¿°±â»ê. Áö¼ÓÀûÀÎ ½ÉÈ«»öÀ» °®´Â´Ù.
  • phosphoric acid
    Àλê
    ¿À»êÈ­ÀÎ PO°¡ ¼öÈ­ÇÏ¿© »ý±â´Â ÀÏ·ÃÀÇ »ê mPO, nHOÀÇ ÃÑĪ. ¸ÞŸ Àλê, ÇÇ·Î Àλê, ¿À¸£Åä Àλê, »ïÀλê, »çÀÎ»ê µîÀÌ ÀÖ°í, ÀÌ ¹Û¿¡ ¸ÞŸ ÀλêÀÇ ÁßÇÕ¿¡ ÀÇÇØ¼­ »ý±â´Â Æú¸® ¸ÞŸ ÀλêÀÇ °è¿­µµ ÀÖÀ¸³ª, ÀϹÝÀûÀ¸·Î´Â ¿À¸£Åä ÀλêÀ» °¡¸®Å²´Ù. ÀλêÀÇ ¼ºÁúÀº ¹«»ö, ¹«ÃëÀÇ Á¡¼ºµµ°¡ Å« ¾×üÀ̸ç, ³óµµ°¡ ³ô¾ÆÁö¸é °áÁ¤È­Çϱ⠽±´Ù. ³ì´ÂÁ¡ 42.35 ¡É, ºñÁß 1.834ÀÌ´Ù. Á¶ÇؼºÀÌ ÀÖ°í, 100 gÀÇ ¹°¿¡ 20 ¡É¿¡¼­ 542 g ³ì´Â´Ù. ºñÈֹ߼ºÀÌ¸ç °¡¿­Çϸé ÇÇ·Î ÀλêÀ̳ª Æú¸® ÀλêÀÌ µÇ°í, ´õ °¡¿­ÇÏ¸é ¸ÞŸ ÀλêÀÌ µÈ´Ù. ¾ËÄڿÿ¡µµ ³ì´Â´Ù. ±Ý¼Ó ¹× ±× »êÈ­¹°À» °Ý·ÄÇÏ°Ô Ä§½ÄÇÑ´Ù. ÀϹÝÀûÀ¸·Î »ýü ³»¿¡¼­´Â Àλê ÇüÅ·Î, »ý¹°°è¿¡¼­´Â Àλ꿰 ¶Ç´Â ÀÎ»ê ¿¡½ºÅ׸£ÀÇ ÇüÅ·ΠÇÙ»ê, ÀÎ ´Ü¹éÁú, ÀÎ ÁöÁú µî »ýüÀÇ ÁÖ¿ä ±¸¼º ¼ººÐÀ» Çü¼ºÇÑ´Ù. °í¿¡³ÊÁö ÀÎ»ê °áÇÕÀ» ¸¸µé¾î ¿¡³ÊÁö ¿î¹ÝüÀÇ ±¸½ÇÀ» ÇÏ´Â µî, »ýÈ­Çлó Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
  • polyacrylic acid
    Æú¸® ¾ÆÅ©¸±¸¯ »ê
  • polyenic acid
    Æú¸®¿£»ê
    ź¼ÒüÀÇ ÀÌÁß °áÇÕÀÌ µÎ°³ ÀÌ»ó Á¸ÀçÇÏ´Â Áö¹æ»ê.
  • polyunsaturate fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
    ¿À¸£Åä ÀλêÀ» 200-300µµ·Î ¿À·¡ °¡¿­ÇÒ ¶§ »ý±â´Â Å« °áÁ¤.
  • pyruvic acid
    ÆÄÀÌ·çºó»ê, Ãʼº Æ÷µµ»ê
    ź¼öÈ­¹° ´ë»çÀÇ Áß°£ ¹°Áú. ¶ó½Ã¹Ì »êÀ̳ª ÁÖ¼®»êÀÇ °Ç·ù¿¡ ÀÇÇØ »ý¼ºµÉ ¼ö ÀÖ´Ù.
  • quinaldinic acid
    Ű³¯µò»ê
  • quinolinic acid
    Ű³î¸°»ê
    ¹«»öÀÇ ÁÖ»ó °áÁ¾À¸·Î, Ű³î¸°ÀÇ »êÈ­ »ý¼º¹°.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 14
amino acid isomerases <enzyme> Enzymes that catalyze either the racemization or epimerization of chiral centres within amino acids or derivatives.
Registry number: EC 5.1.1.-
(12 Dec 1998)
amino acid naphthylamidases <enzyme> Registry number: EC 3.4.11.
(12 Dec 1998)
amino acid neurotransmitters Amino acids released by neurons as intercellular messengers. Among the amino acid neurotransmitters are glutamate (glutamic acid) and gaba which are, respectively, the most common excitatory and inhibitory neurotransmitters in the central nervous system.
(12 Dec 1998)
amino acid oxidases Flavoenzymes oxidizing, with O2 and H20, either l-or d-amino acids specifically, to the corresponding 2-keto acids, NH3 and H2O2.
Compare: amino acid dehydrogenases, yellow enzyme.
(05 Mar 2000)
amino acid oxidoreductases <enzyme> A class of enzymes that catalyze oxidation-reduction reactions of amino acids.
Registry number: EC 1.4.
(12 Dec 1998)
amino acid permease <enzyme> A widely distributed group of large Integral membrane proteins, required for the entry of amino acids into cells.
(18 Nov 1997)
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
amino acid receptor <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor.
(18 Nov 1997)
amino acid sequence The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.
(12 Dec 1998)
amino acid substitution The naturally occurring or experimentally induced replacement of one or more amino acids in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
(12 Dec 1998)
amino acid transmitter <biochemistry> Amino acids released as neurotransmitter substances from nerve terminals and acting on postsynaptic receptors for example _ aminobutyric acid (GABA) and glycine that are fast inhibitory transmitters in the mammalian central nervous system.
Glutamate and aspartate mediate fast excitatory transmission. Strychnine (for glycine) and bicuculline for GABA) are blocking agents for amino acid action.
(18 Nov 1997)
aminocaproic acid <chemistry> A group of compounds that are derivatives of aminohexanoic acids.
<haematology> An antifibrinolytic agent, used to prevent bleeding in haemophilia, and after heart and prostate surgery when plasminogen or urokinase may be activated.
(05 Mar 2000)
aminocarboxylic acid <biochemistry> A class of organic molecules that containing an amino group and can combine in linear arrays to form proteins in living organisms.
There are twenty common amino acids: alanine, arginine, aspargine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
They are key components in all living things from which proteins are synthesised by formation of peptide bonds during ribosomal translation of messenger RNA.
All the amino acids have the L configuration, except glycine which is not optically active. Other amino acids occurring in proteins, such as hydroxyproline in collagen, are formed by post translational enzymatic modification of amino acid residues in polypeptide chains.
There are also several important amino acids, such as the neurotransmitter y aminobutyric acid, that have no relation to proteins.
Amino acids can now be produced by biotechnology in bulk using fermentation and biotransformation.
Acronym: AA
(13 Nov 1997)
aminocitric acid HOOCCH(NH3+)C(COOH)(OH)CH2CO; OH;found in acid hydrolysates of ribonucleoprotein in human spleen.
(05 Mar 2000)
aminoethanoic acid <amino acid, physiology> The simplest amino acid. It is a common residue in proteins, especially collagen and elastin and is not optically active.
It is also a major inhibitory neurotransmitter in spinal cord and brainstem of vertebrate central nervous system.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 14
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 14
ÅëÇÕ°Ë»ö ¿Ï·á